Arone

Clinical trials and research traditionally existed outside of the care administered within local hospitals and physicians’ offices. Physicians weren’t always aware of what research was being conducted, and patients had little idea research that could potentially improve their outcome or benefit their health was occurring at all. Only Elligo enables broader participation in clinical research than ever before with access to over 150 million patients and their data, allowing physicians to provide research as a care option to patients who otherwise wouldn’t have access to clinical research. Traditional recruitment methods are constrained by limitations such as patient proximity to a specific site where research is conducted. Research has also shown that patients prefer to engage in a study with their trusted healthcare physician.

Science 37 is a clinical research company specializing in decentralized clinical trials through its Metasite model, which eliminates physical proximity as a barrier, enabling patients to participate from anywhere. This approach expands access to over 90% of patients who are unable to participate in traditional site-based research, offering the recruiting power of 20 sites in one and providing the flexibility patients need to participate from anywhere. The Metasite is powered by a proprietary platform that drives uniform study orchestration, guiding the workflow of patients and study staff, and capturing study data without the need for manual reentry. This centralization of people, processes, and platforms delivers built-in protocol compliance, ensuring greater compliance and high-quality data. Science 37's in-house medical teams, telemedicine investigators, and mobile nurses have extensive experience in remote trial conduct across various therapeutic areas, ensuring broad reach.